Search Results 41-50 of 19669 for Receptor

  1. The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer - Mayo Clinic

    The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer · Share · Facebook ...

  2. Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer - Mayo Clinic

    The purpose of this study is to study to collect tissue samples from patients with early stage hormone receptor-positive HER2-negative breast cancer.

  3. A Study to Evaluate Estrogen Receptor (ER) Reactivation Therapy for Breast Cancer - Mayo Clinic

    About this study. The purpose of this study is to evaluate whether or not treatment with alternating 17B-estradiol / anti-estrogen therapies on a defined ...

  4. Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation - Mayo Clinic

    Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation · Overview · Participation ...

  5. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

    A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple ...

  6. Autoimmune encephalitis - Symptoms and causes - Mayo Clinic

    Anti-AMPA receptor encephalitis. This type of AE usually affects women and can cause confusion and memory loss. The average age of diagnosis is age 62. Anti- ...

  7. OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer - Mayo Clinic

    OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

  8. Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer - Mayo Clinic

    This pilot, phase II trial studies how well everolimus and letrozole work in treating patients with hormone receptor positive ovarian, fallopian tube, or ...

  9. Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers - Mayo Clinic

    Enzalutamide is not FDA approved to treat salivary gland cancer, but it has already been FDA-approved to treat other cancers. Participation eligibility.

  10. Anastrozole (oral route) - Side effects & dosage - Mayo Clinic

    Description. Anastrozole is used to treat early hormone receptor-positive breast cancer. It is also used for first-line treatment of hormone ...